Japan approves Biomerica's 10-minute PSA (prostate specific antigen) test:
This article was originally published in Clinica
The Japanese Ministry of Health has approved for sale Biomerica's 10-minute, disposable prostate specific antigen (PSA) test for prostate cancer screening. The EZ-PSA is an easy-to-use, one-step, finger-prick-based blood test for use in a doctor's office. It indicates whether a patient has an elevated level of PSA, which can provide an early marker for the disease. "We are very optimistic about this market because the incidence of prostate cancer in Japan has been on the rise over the past 10 years" says Francis Capitanio, president of the Newport Beach, California, company.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.